adhd - PMC - NCBI

Result Filters

You searched 8+ million full text articles

Try this search in 34+ million citations and abstracts

PMC Full-Text Search Results

Items: 1 to 20 of 113968

<< First< Prev

Page of 5699

Next >Last >>

Select item 83289331.

The World Federation of ADHD International Consensus Statement: 208 Evidence-based Conclusions about the Disorder

Stephen V. Faraone, Tobias Banaschewski, David Coghill, Yi Zheng, Joseph Biederman, Mark A. Bellgrove, Jeffrey H. Newcorn, Martin Gignac, Nouf M. Al Saud, Iris Manor, Luis Augusto Rohde, Li Yang, Samuele Cortese, Doron Almagor, Mark A. Stein, Turki H. Albatti, Haya F. Aljoudi, Mohammed M.J. Alqahtani, Philip Asherson, Lukoye Atwoli, Sven Bölte, Jan K. Buitelaar, Cleo L. Crunelle, David Daley, Søren Dalsgaard, Manfred Döpfner, Stacey Espinet, Michael Fitzgerald, Barbara Franke, Manfred Gerlach, Jan Haavik, Catharina A. Hartman, Cynthia M. Hartung, Stephen P. Hinshaw, Pieter J. Hoekstra, Chris Hollis, Scott H. Kollins, J.J. Sandra Kooij, Jonna Kuntsi, Henrik Larsson, Tingyu Li, Jing Liu, Eugene Merzon, Gregory Mattingly, Paulo Mattos, Suzanne McCarthy, Amori Yee Mikami, Brooke S.G. Molina, Joel T. Nigg, Diane Purper-Ouakil, Olayinka O. Omigbodun, Guilherme V. Polanczyk, Yehuda Pollak, Alison S. Poulton, Ravi Philip Rajkumar, Andrew Reding, Andreas Reif, Katya Rubia, Julia Rucklidge, Marcel Romanos, J. Antoni Ramos-Quiroga, Arnt Schellekens, Anouk Scheres, Renata Schoeman, Julie B. Schweitzer, Henal Shah, Mary V. Solanto, Edmund Sonuga-Barke, César Soutullo, Hans-Christoph Steinhausen, James M. Swanson, Anita Thapar, Gail Tripp, Geurt van de Glind, Wim van den Brink, Saskia Van der Oord, Andre Venter, Benedetto Vitiello, Susanne Walitza, Yufeng Wang

Neurosci Biobehav Rev. Author manuscript; available in PMC 2021 Sep 1.

Published in final edited form as: Neurosci Biobehav Rev. 2021 Sep; 128: 789–818. Published online 2021 Feb 4. doi: 10.1016/j.neubiorev.2021.01.022

PMCID:: PMC8328933

Abstract Article PDF–563K

Select item 63792452.

Live fast, die young? A review on the developmental trajectories of ADHD across the lifespan

Barbara Franke, Giorgia Michelini, Philip Asherson, Tobias Banaschewski, Andrea Bilbow, Jan K. Buitelaar, Bru Cormand, Stephen V. Faraone, Ylva Ginsberg, Jan Haavik, Jonna Kuntsi, Henrik Larsson, Klaus-Peter Lesch, J. Antoni Ramos-Quiroga, János M. Réthelyi, Marta Ribases, Andreas Reif

Eur Neuropsychopharmacol. 2018 Oct; 28(10): 1059–1088. doi: 10.1016/j.euroneuro.2018.08.001

PMCID:: PMC6379245

Abstract Article

Select item 70672823.

Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents

Mark L. Wolraich, Joseph F. Hagan, Jr, Carla Allan, Eugenia Chan, Dale Davison, Marian Earls, Steven W. Evans, Susan K. Flinn, Tanya Froehlich, Jennifer Frost, Joseph R. Holbrook, Christoph Ulrich Lehmann, Herschel Robert Lessin, Kymika Okechukwu, Karen L. Pierce, Jonathan D. Winner, William Zurhellen, SUBCOMMITTEE ON CHILDREN AND ADOLESCENTS WITH ATTENTION-DEFICIT/HYPERACTIVE DISORDER

Pediatrics. Author manuscript; available in PMC 2020 Oct 1.

Published in final edited form as: Pediatrics. 2019 Oct; 144(4): e20192528. doi: 10.1542/peds.2019-2528

Correction in:: Pediatrics. 2020 Feb 28

PMCID:: PMC7067282

Abstract Article PDF–595K

Select item 100233374.

ANNUAL RESEARCH REVIEW: PERSPECTIVES ON PROGRESS IN ADHD SCIENCE - FROM CHARACTERISATION TO CAUSE

Edmund J S Sonuga-Barke, Stephen P. Becker, Sven Bölte, Francisco Xavier Castellanos, Barbara Franke, Jeffery H. Newcorn, Joel T. Nigg, Luis Augusto Rohde, Emily Simonoff

J Child Psychol Psychiatry. Author manuscript; available in PMC 2023 Apr 1.

Published in final edited form as: J Child Psychol Psychiatry. 2023 Apr; 64(4): 506–532. Published online 2022 Oct 11. doi: 10.1111/jcpp.13696

PMCID:: PMC10023337

Abstract Article PDF–471K

Select item 107555835.

A systematic meta-review of systematic reviews on attention deficit hyperactivity disorder

Ashmita Chaulagain, Ingvild Lyhmann, Anne Halmøy, Tarjei Widding-Havneraas, Olav Nyttingnes, Ingvar Bjelland, Arnstein Mykletun

Eur Psychiatry. 2023; 66(1): e90. Published online 2023 Nov 17. doi: 10.1192/j.eurpsy.2023.2451

PMCID:: PMC10755583

Abstract Article PDF–983K

Select item 80425336.

Overdiagnosis of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents: A Systematic Scoping Review

Luise Kazda, Katy Bell, Rae Thomas, Kevin McGeechan, Rebecca Sims, Alexandra Barratt

JAMA Netw Open. 2021 Apr; 4(4): e215335. Published online 2021 Apr 12. doi: 10.1001/jamanetworkopen.2021.5335

PMCID:: PMC8042533

Abstract Article

Select item 100424357.

Methylphenidate for children and adolescents with attention deficit hyperactivity disorder (ADHD)

Cochrane Database Syst Rev. 2023; 2023(3): CD009885. Published online 2023 Mar 27. doi: 10.1002/14651858.CD009885.pub3

PMCID:: PMC10042435

Abstract Article PDF–8.4M

Select item 75086368.

ADHD: Current Concepts and Treatments in Children and Adolescents

Renate Drechsler, Silvia Brem, Daniel Brandeis, Edna Grünblatt, Gregor Berger, Susanne Walitza

Neuropediatrics. 2020 Oct; 51(5): 315–335. Published online 2020 Jun 19. doi: 10.1055/s-0040-1701658

PMCID:: PMC7508636

Abstract Article PDF–371K

Select item 95485489.

Neuroprotection in late life attention-deficit/hyperactivity disorder: A review of pharmacotherapy and phenotype across the lifespan

Cintya Nirvana Dutta, Leonardo Christov-Moore, Hernando Ombao, Pamela K. Douglas

Front Hum Neurosci. 2022; 16: 938501. Published online 2022 Sep 26. doi: 10.3389/fnhum.2022.938501

PMCID:: PMC9548548

Abstract Article PDF–3.2M

Select item 1012266510.

Reduced inferior fronto-insular-thalamic activation during failed inhibition in young adults with combined ASD and ADHD compared to typically developing and pure disorder groups

Steve Lukito, Owen G. O’Daly, David J. Lythgoe, John Hodsoll, Stefanos Maltezos, Mark Pitts, Emily Simonoff, Katya Rubia

Transl Psychiatry. 2023; 13: 133. Published online 2023 Apr 22. doi: 10.1038/s41398-023-02431-4

PMCID:: PMC10122665

Abstract Article PDF–1.1M

Select item 742260211.

Females with ADHD: An expert consensus statement taking a lifespan approach providing guidance for the identification and treatment of attention-deficit/ hyperactivity disorder in girls and women

Susan Young, Nicoletta Adamo, Bryndís Björk Ásgeirsdóttir, Polly Branney, Michelle Beckett, William Colley, Sally Cubbin, Quinton Deeley, Emad Farrag, Gisli Gudjonsson, Peter Hill, Jack Hollingdale, Ozge Kilic, Tony Lloyd, Peter Mason, Eleni Paliokosta, Sri Perecherla, Jane Sedgwick, Caroline Skirrow, Kevin Tierney, Kobus van Rensburg, Emma Woodhouse

BMC Psychiatry. 2020; 20: 404. Published online 2020 Aug 12. doi: 10.1186/s12888-020-02707-9

PMCID:: PMC7422602

Abstract Article PDF–1.5M

Select item 694792412.

Brain imaging genetics in ADHD and beyond – mapping pathways from gene to disorder at different levels of complexity

Marieke Klein, Marten Onnink, Marjolein van Donkelaar, Thomas Wolfers, Benjamin Harich, Yan Shi, Janneke Dammers, Alejandro Arias-Vásquez, Martine Hoogman, Barbara Franke

Neurosci Biobehav Rev. Author manuscript; available in PMC 2020 Jan 8.

Published in final edited form as: Neurosci Biobehav Rev. 2017 Sep; 80: 115–155. Published online 2017 Jan 31. doi: 10.1016/j.neubiorev.2017.01.013

PMCID:: PMC6947924

Abstract Article PDF–1.0M

Select item 1004964613.

Epilepsy and Attention Deficit Hyperactivity Disorder: Connection, Chance, and Challenges

Hueng-Chuen Fan, Kuo-Liang Chiang, Kuang-Hsi Chang, Chuan-Mu Chen, Jeng-Dau Tsai

Int J Mol Sci. 2023 Mar; 24(6): 5270. Published online 2023 Mar 9. doi: 10.3390/ijms24065270

PMCID:: PMC10049646

Abstract Article PDF–1.0M

Select item 1010354614.

Polyunsaturated fatty acids (PUFA) for attention deficit hyperactivity disorder (ADHD) in children and adolescents

Cochrane Database Syst Rev. 2023; 2023(4): CD007986. Published online 2023 Apr 14. doi: 10.1002/14651858.CD007986.pub3

PMCID:: PMC10103546

Abstract Article PDF–1.3M

Select item 651346415.

Amphetamines for attention deficit hyperactivity disorder (ADHD) in adults

Xavier Castells, Lídia Blanco‐Silvente, Ruth Cunill, Cochrane Developmental, Psychosocial and Learning Problems Group

Cochrane Database Syst Rev. 2018; 2018(8): CD007813. Published online 2018 Aug 9. doi: 10.1002/14651858.CD007813.pub3

PMCID:: PMC6513464

Abstract Article PDF–1.4M

Select item 869163616.

The impact of psychological theory on the treatment of Attention Deficit Hyperactivity Disorder (ADHD) in adults: A scoping review

Rebecca E. Champ, Marios Adamou, Barry Tolchard

PLoS One. 2021; 16(12): e0261247. Published online 2021 Dec 21. doi: 10.1371/journal.pone.0261247

PMCID:: PMC8691636

Abstract Article PDF–1.2M

Select item 902702817.

University students with attention deficit hyperactivity disorder (ADHD): a consensus statement from the UK Adult ADHD Network (UKAAN)

Jane A. Sedgwick-Müller, Ulrich Müller-Sedgwick, Marios Adamou, Marco Catani, Rebecca Champ, Gísli Gudjónsson, Dietmar Hank, Mark Pitts, Susan Young, Philip Asherson

BMC Psychiatry. 2022; 22: 292. Published online 2022 Apr 22. doi: 10.1186/s12888-022-03898-z

PMCID:: PMC9027028

Abstract Article PDF–2.5M

Select item 1100940718.

An updated review on animal models to study attention-deficit hyperactivity disorder

Daegeon Kim, Dhananjay Yadav, Minseok Song

Transl Psychiatry. 2024; 14: 187. Published online 2024 Apr 11. doi: 10.1038/s41398-024-02893-0

PMCID:: PMC11009407

Abstract Article PDF–1.0M

Select item 817992819.

Genetic variations influence brain changes in patients with attention-deficit hyperactivity disorder

Santosh K. Yadav, Ajaz A. Bhat, Sheema Hashem, Sabah Nisar, Madeeha Kamal, Najeeb Syed, Mohamed-Ramzi Temanni, Rakesh K. Gupta, Saddat Kamran, Muhammad Waqar Azeem, Amit K. Srivastava, Puneet Bagga, Sanjeev Chawla, Ravinder Reddy, Michael P. Frenneaux, Khalid Fakhro, Mohammad Haris

Transl Psychiatry. 2021; 11: 349. Published online 2021 Jun 5. doi: 10.1038/s41398-021-01473-w

PMCID:: PMC8179928

Abstract Article PDF–2.4M

Select item 1082766920.

White matter alterations in Attention-Deficit/Hyperactivity Disorder (ADHD): a systematic review of 129 diffusion imaging studies with meta-analysis

Valeria Parlatini, Takashi Itahashi, Yeji Lee, Siwei Liu, Thuan T. Nguyen, Yuta Y. Aoki, Stephanie J. Forkel, Marco Catani, Katya Rubia, Juan H. Zhou, Declan G. Murphy, Samuele Cortese

Mol Psychiatry. 2023; 28(10): 4098–4123. Published online 2023 Jul 21. doi: 10.1038/s41380-023-02173-1

PMCID:: PMC10827669

Abstract Article PDF–1.9M

<< First< Prev

Page of 5699

Next >Last >>

Supplemental Content

Filter your results:

Manage Filters

PMC Images search for adhd

Figure 1

Days to return to school (cumulative percentage curves). Cumulative percentage curves by group of time to return to school. The featured percentages are as follows: 1 day (10.2% of those with ADHD, 11.5% of those without ADHD), 3 days (29.5% of those with ADHD, 27.3% of those without ADHD), 5 days (43.2% of those with ADHD, 40. 7% of those without ADHD) 7 days (54.5% of those with ADHD, 55.3% of those without), 10 days (64.8% of those with ADHD, 67.5% of those without ADHD), 14 days (83.0% of those. with ADHD, 77.8% of those without), and 21 days post injury (90.9% of those with ADHD, 88. 7% of those without ADHD).

Adolescents With ADHD Do Not Take Longer to Recover From Concussion

Front Pediatr. 2020;8:606879.
Figure 1.Estimated Proportion of Children Aged 5–17 Years with ADHD, County Level, 2016–2018

The lightest color represents counties with an ADHD estimate of 11% or lower. The second color in the gradient represents counties with an ADHD estimate between 12% and 15%. The third color in the gradient represents counties with an ADHD estimate between 16% and 19%. The darkest color represents counties with an ADHD estimate of 20% or higher. The lighter the color of the county, the lower the ADHD prevalence estimate. The darker the color of the county, the higher the ADHD prevalence estimate. For example, counties in the southern part of the U.S. have higher ADHD prevalence than counties in western states.

County-Level Prevalence Estimates of ADHD in Children in the United States

Ann Epidemiol. ;79:56-64.
Figure 1

Genome-wide association Manhattan plots. The Manhattan plots display level of significance for each SNP, organized by chromosomal position from chromosomes 1–22. Panel A presents ADHD inattention, Panel B presents ADHD hyperactivity-impulsivity, and Panel C presents ADHD total score The blue line indicates suggestive significance (p<10⁻⁵). No SNPs achieved genome-wide significance (p<5x10⁻⁸).
Figure 1(b). Genome-wide association Manhattan plots. The Manhattan plots display level of significance for each SNP, organized by chromosomal position from chromosomes 1–22. Panel A presents ADHD inattention, Panel B presents ADHD hyperactivity-impulsivity, and Panel C presents ADHD total score The blue line indicates suggestive significance (p<10⁻⁵). No SNPs achieved genome-wide significance (p<5x10⁻⁸).
Figure 1(c). Genome-wide association Manhattan plots. The Manhattan plots display level of significance for each SNP, organized by chromosomal position from chromosomes 1–22. Panel A presents ADHD inattention, Panel B presents ADHD hyperactivity-impulsivity, and Panel C presents ADHD total score The blue line indicates suggestive significance (p<10⁻⁵). No SNPs achieved genome-wide significance (p<5x10⁻⁸).

Genetic Influences on ADHD Symptom Dimensions: Examination of A Priori Candidates, Gene-based Tests, Genome-wide Variation, and SNP Heritability

Am J Med Genet B Neuropsychiatr Genet. ;174(4):458-466.
Fig. 6.

Slope (A and B) and offset (C and D) for the stimulant-treated attention-deficit/hyperactivity disorder (ADHD) group after medication washout (ADHD+; shaded bars, shaded lines) and the age- and sex-matched typically developing (TD; closed bars, solid lines) and medication-naive ADHD (ADHD−; open bars, dashed lines) subgroups. Error bars are ±SD. A: ADHD− has steeper slopes compared with both TD and ADHD+ when averaged across participants and electrodes. B: slopes were steeper in ADHD− for all electrodes tested. C: ADHD− has greater offset compared with TD and ADHD+ when averaged across participants and electrodes. D: this pattern holds when electrodes are considered individually. *P < 0.05, significant difference between TD and ADHD− after false discovery rate (FDR) correction. #P < 0.05, significant differences between ADHD− and ADHD+ after FDR correction.

EEG power spectral slope differs by ADHD status and stimulant medication exposure in early childhood

J Neurophysiol. 2019 Dec 1;122(6):2427-2437.